Drug News Express | Zaiding Pharmaceuticals Introduces Small Molecule New Drugs for Alzheimer's Disease Approved for Clinical Use
海角七号
发表于 2024-3-4 10:07:02
243
0
0
On February 29th, according to the official website of the Drug Evaluation Center of the National Medical Products Administration, the Class 1 new drug KarXT capsules applied for by Karuna Company have obtained implied permission for clinical trials and are planned to be developed for the treatment of mental and behavioral symptoms related to Alzheimer's disease. Zaiding Pharmaceutical owns the development, production, and commercialization rights of KarXT in Greater China.
According to the medical Rubik's cube data, KarXT (xanomeline tropium) is an oral M1/M4 type muscarine acetylcholine receptor agonist developed by Karuna company. The approved clinical indication for this is Alzheimer's disease-related psychobehavioral symptoms.
Hang Seng Pharmaceutical ETF (159892) holds positions in well-known innovative pharmaceutical industry chain enterprises such as Zhongding Pharmaceutical, WuXi AppTec, WuXi AppTec, and BeiGene, with high R&D investment and strong innovation attributes. With the progress of domestic technology, overseas market business has also been steadily advancing in recent years.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
- Can I choose SF Express on Taobao and Tmall? An additional 5 yuan postage fee is required! Double Eleven service roll up
- Dialogue with Express Overseas Warriors: Fighting in Southeast Asia, light assets or heavy investment? Where is the incremental space?
- Johnson&Johnson's drug Zebaike has been approved in China
- JD Express International launches delivery service to 7 Southeast Asian countries
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Abbott announces the launch of its new women's health drug Fenyouning in China
- Most of the popular Chinese concept stocks before the US stock market rose, while Zhongtong Express rose nearly 7%
-
据媒体报道,OpenAI正准备推出一款代号为“Operator”的全新AI助理产品,可以自动执行各种复杂操作,包括编写代码、预订旅行、自动电商购物等。根据内部员工爆料,OpenAI领导层预计将在2025年1月发布该产品,首 ...
- 永远的希望
- 昨天 11:06
- 支持
- 反对
- 回复
- 收藏
-
【小摩辣评“特朗普2.0”:关税大棒料打击经济、重燃通胀!】摩根大通资产管理公司(JPMorgan Asset Management)首席全球市场策略师David Kelly周三表示,当选总统特朗普激进的关税计划,可能会减缓全球经济,并给 ...
- besharp
- 昨天 12:37
- 支持
- 反对
- 回复
- 收藏
-
本报讯 (记者李豪悦)11月12日,腾讯音乐娱乐集团(以下简称“腾讯音乐”)宣布其截至2024年9月30日止第三季度的未经审计财务业绩。 2024年第三季度,腾讯音乐娱乐集团业绩表现稳健,总收入为70.2亿元,同 ...
- 覃志辉
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
新华财经上海11月13日电芯片制造商英伟达和软银集团的电信部门软银公司周三表示,两家公司已经试运行了全球首个人工智能和5G电信网络。 两家公司表示,该网络可以同时运行人工智能和5G工作负载,这一过程被 ...
- 惡魔獵人
- 前天 12:36
- 支持
- 反对
- 回复
- 收藏